American President Donald Trump has rated a malaria medicine For its part, it is classified as a ‘pioneer’ for the treatment of new type of coronavirus But this causes disagreements among experts in the White House.
The Axios site states that there was a controversy among the members of the Covid-19 Mission fighting force in the White House, very serious about the hydroxychloroquine medicine that is spoken about frequently by Trump. White House business consultant Peter Navarro has brought to the agenda the research case that supports Trump’s assessment that medicine is positive in the treatment of Covid-19.
Navarro has also argued that distribution in epidemic areas is a decision, depositing this medicine in the United States.
But against this statement, another important member of the Covid-19 Mission Fighting Force, the president of the National Institute of Allergy and Communicable Diseases, doctor Anthony Fauci has argued that there is insufficient research on the drug and the White House must have a position. more cautious.
There was tension in the assembly chamber when Fauci said that they need more tests to prove that this medicine is useful in treating Covid-19.
A group of the White House team supports Navarro, another party alleges that Fauci is right.
–